Idenix Pharmaceuticals (IDIX)

[go seek]

If telbivudine sales were to pick up, and I emphasize (if)
like Baraclude sales did in its 2nd year on the market. The dollar flow to Idenix's bottom would be substantial...

trying to get a handle on how much Baraclude sales increased 1st year over 2nd... know we have the data in our posts.

I see the move to Viread and the downplay of Hepsera as a possible positive to telbivudine... (am I off base?) ... Viread will be another new kid on the HBV block, while Hepsera has been an established major player in HBV market.